A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Silence Therapeutics Plc ADR’s current trading price is -81.85% away from its 52-week high, while its distance from the 52-week low is -4.91%. The stock’s price range for this time frame has been between $5.29 and $27.72. The trading volume of the company’s shares in the Healthcare reached around 1.3 million for the day, which was evidently higher than the average daily volume of 0.51 million over the last three months.
Silence Therapeutics Plc ADR’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $27.72 on 03/14/24, and the lowest price during that time was $5.29, recorded on 01/16/25.
How Financial Performance Impacts Market Capitalization
Silence Therapeutics Plc ADR (SLN) has experienced a quarterly decline of -72.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 237.47M and boasts a workforce of 109 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.68, with a change in price of -10.50. Similarly, Silence Therapeutics Plc ADR recorded 390,966 in trading volume during the last 100 days, posting a change of -67.61%.
How SLN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SLN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
SLN Stock Stochastic Average
The raw stochastic average for Silence Therapeutics Plc ADR over the last 50 days is presently at 1.56%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 6.44%. Further, the company’s Stochastic %K and %D values for the last 20 days were 2.91% and 4.61%, respectively.
SLN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -26.89% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -75.37%. Over the past 30 days, the price of SLN has leaped by -22.02%. And in the last five days, it has fallen by -20.66%.
